Objective To estimate the effectiveness of the inactivated whole virus vaccine, CoronaVac (Sinovac
Biotech), against symptomatic covid-19 in the elderly population of São Paulo state, …

Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health concern. To
evaluate existing evidence regarding treatment regimens for MDR tuberculosis, we used a …

Background COVID-19 manifests with respiratory, systemic, and gastrointestinal (GI)
symptoms. SARS-CoV-2 RNA is detected in respiratory and fecal samples, and recent reports …

Background Efforts to quantify the global burden of enteric fever are valuable for understanding
the health lost and the large-scale spatial distribution of the disease. We present the …

During infectious disease outbreaks, data collected through health institutions and official
reporting structures may not be available for weeks, hindering early epidemiologic assessment…

(See the Editorial Commentary by Vernon and Villarino, on pages 792–3 .) Background.
The risk of progression to active tuberculosis is greatest in the several years following initial …

Severe acute respiratory syndrome coronavirus 2 infections can cause coronavirus disease
2019 (COVID-19), which manifests with a range of severities from mild illness to life-…

Rationale: The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
(TB) epidemics are rapidly expanding in South Africa. Our initial report of HIV-associated …

Obesity, characterized by chronic low-grade inflammation of the adipose tissue, is
associated with adverse coronavirus disease 2019 (COVID-19) outcomes, yet the underlying …

Background Tens of millions of children are exposed to Mycobacterium tuberculosis
globally every year; however, there are no contemporary estimates of the risk of developing …